Your browser doesn't support javascript.
loading
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment.
Su, Po-Lan; Yang, Szu-Chun; Chen, Yi-Lin; Wu, Yi-Lin; Lin, Chia-Ying; Chang, Wei-Yuan; Tseng, Yau-Lin; Lai, Wu-Wei; Ho, Chung-Liang; Lin, Chien-Chung; Su, Wu-Chou.
Affiliation
  • Su PL; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Yang SC; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chen YL; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Wu YL; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lin CY; Department of Nursing, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chang WY; Department of Diagnostic Radiology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Tseng YL; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lai WW; Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Ho CL; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lin CC; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Su WC; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Cancer Med ; 8(13): 5939-5947, 2019 10.
Article in En | MEDLINE | ID: mdl-31433117

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Circulating Tumor DNA / Aniline Compounds / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: Taiwán Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Circulating Tumor DNA / Aniline Compounds / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: Taiwán Country of publication: Estados Unidos